Dagny Holle-Lee
Essen, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 40 publications
Tolerability, safety, and efficacy of atogepant versus topiramate in adults with migraine (TEMPLE): a randomised, head-to-head, phase 3b trial.
Journal: The Lancet. Neurology
Published: March 10, 2026
Practical tips for migraine prophylaxis
Journal: Deutsche medizinische Wochenschrift (1946)
Published: February 23, 2026
Transgender health, migraine and headache-Underestimated associations, limited data situation
Journal: Schmerz (Berlin, Germany)
Published: December 03, 2025
Open-Label Placebos as Adjunct for the Preventive Treatment of Migraine: A Randomized Clinical Trial.
Journal: JAMA network open
Published: October 08, 2025
Long-term safety, efficacy and functional outcomes of atogepant for the preventive treatment of migraine.
Journal: Cephalalgia : an international journal of headache
Published: August 20, 2025
Erenumab for Chronic Cluster Headache: A Randomized Clinical Trial.
Journal: JAMA network open
Published: June 17, 2025
Digitization in the diagnosis and treatment of headache
Journal: MMW Fortschritte der Medizin
Published: November 22, 2024
Benefit-risk assessment based on number needed to treat and number needed to harm: Atogepant vs. calcitonin gene-related peptide monoclonal antibodies.
Journal: Cephalalgia : an international journal of headache
Published: November 19, 2024
Optimized communication during risk disclosure to reduce nocebo headache after lumbar puncture-a study protocol for a randomized controlled clinical trial.
Journal: Frontiers in psychology
Published: November 03, 2024
A Lot is Happening in Migraine and Headache Therapy!
Journal: Fortschritte der Neurologie-Psychiatrie
Published: July 18, 2024
Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse in the Randomized, Double-Blind, Phase 3 PROGRESS Trial.
Journal: Neurology
Published: June 26, 2024
Last Updated: 09/26/2026